MacroGenics Total Assets from 2010 to 2024

MGNX Stock

USD 3.21 0.07 2.13%

MacroGenics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 287.5 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2011-12-31

Previous Quarter

201.1 M

Current Value

264.5 M

Quarterly Volatility

100.3 M

Yuan Drop

Covid

Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.

Check out the analysis of MacroGenics Correlation against competitors.

For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Total Assets Growth Pattern

Below is the plot of the Total Assets of MacroGenics over the last few years. Total assets refers to the total amount of MacroGenics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MacroGenics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. MacroGenics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 298.42 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

MacroGenics Total Assets Regression Statistics

	Arithmetic Mean	249,881,391
	Geometric Mean	208,514,259
	Coefficient Of Variation	47.85
	Mean Deviation	102,750,734
	Median	298,418,000
	Standard Deviation	119,561,486
	Sample Variance	14294.9T
	Range	325M
	R-Value	0.73
	Mean Square Error	7079T
	R-Squared	0.54
	Significance	0
	Slope	19,648,890
	Total Sum of Squares	200129.3T

MacroGenics Total Assets History

	2024	287.5 M
	2023	298.4 M
	2022	280.5 M
	2021	335.2 M
	2020	378.7 M
	2019	312.5 M
	2018	332.1 M

Other Fundumenentals of MacroGenics

Intangibles To Total Assets

MacroGenics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Short Term Investments	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	-0.33	-0.58	-0.53	-0.13	0.39	0.21	0.99	-0.28	0.84	0.76	0.93	0.74	0.69	0.29	-0.78	-0.7	-0.32	-0.4	0.41
Total Stockholder Equity	0.97		-0.5	-0.66	-0.33	-0.22	0.23	-0.04	0.98	-0.21	0.71	0.68	0.97	0.75	0.5	0.11	-0.66	-0.55	-0.1	-0.21	0.22
Current Deferred Revenue	-0.33	-0.5		0.45	-0.36	0.23	0.67	0.62	-0.39	-0.01	0.04	-0.18	-0.53	-0.44	0.21	0.42	0.01	-0.09	-0.55	-0.44	0.39
Net Debt	-0.58	-0.66	0.45		-0.2	0.43	-0.12	0.27	-0.61	-0.02	-0.25	-0.42	-0.61	-0.1	0.01	0.24	0.14	0.33	-0.28	-0.19	0.31
Retained Earnings	-0.53	-0.33	-0.36	-0.2		-0.3	-0.62	-0.81	-0.44	0.25	-0.83	-0.53	-0.29	-0.38	-0.93	-0.84	0.75	0.73	0.89	0.88	-0.97
Accounts Payable	-0.13	-0.22	0.23	0.43	-0.3		-0.04	0.33	-0.17	-0.2	0.02	-0.05	-0.13	0.02	0.25	0.26	-0.08	-0.08	-0.09	-0.16	0.4
Net Receivables	0.39	0.23	0.67	-0.12	-0.62	-0.04		0.66	0.3	-0.19	0.58	0.48	0.16	-0.05	0.6	0.45	-0.58	-0.65	-0.64	-0.63	0.52
Total Liab	0.21	-0.04	0.62	0.27	-0.81	0.33	0.66		0.11	-0.3	0.56	0.39	-0.07	0.05	0.78	0.74	-0.54	-0.65	-0.86	-0.75	0.77
Total Current Assets	0.99	0.98	-0.39	-0.61	-0.44	-0.17	0.3	0.11		-0.26	0.78	0.67	0.94	0.78	0.62	0.24	-0.7	-0.6	-0.24	-0.3	0.34
Short Term Debt	-0.28	-0.21	-0.01	-0.02	0.25	-0.2	-0.19	-0.3	-0.26		-0.13	-0.27	-0.35	-0.3	-0.3	-0.18	0.32	0.27	0.19	0.21	-0.2
Common Stock	0.84	0.71	0.04	-0.25	-0.83	0.02	0.58	0.56	0.78	-0.13		0.7	0.59	0.58	0.92	0.59	-0.81	-0.75	-0.66	-0.69	0.75
Property Plant Equipment	0.76	0.68	-0.18	-0.42	-0.53	-0.05	0.48	0.39	0.67	-0.27	0.7		0.65	0.36	0.64	0.26	-0.83	-0.89	-0.41	-0.58	0.36
Net Tangible Assets	0.93	0.97	-0.53	-0.61	-0.29	-0.13	0.16	-0.07	0.94	-0.35	0.59	0.65		0.76	0.44	0.07	-0.63	-0.52	-0.04	-0.17	0.19
Short Term Investments	0.74	0.75	-0.44	-0.1	-0.38	0.02	-0.05	0.05	0.78	-0.3	0.58	0.36	0.76		0.53	0.23	-0.58	-0.25	-0.2	-0.19	0.35
Capital Surpluse	0.69	0.5	0.21	0.01	-0.93	0.25	0.6	0.78	0.62	-0.3	0.92	0.64	0.44	0.53		0.7	-0.8	-0.76	-0.78	-0.76	0.88
Deferred Long Term Liab	0.29	0.11	0.42	0.24	-0.84	0.26	0.45	0.74	0.24	-0.18	0.59	0.26	0.07	0.23	0.7		-0.58	-0.58	-0.85	-0.8	0.82
Long Term Debt Total	-0.78	-0.66	0.01	0.14	0.75	-0.08	-0.58	-0.54	-0.7	0.32	-0.81	-0.83	-0.63	-0.58	-0.8	-0.58		0.86	0.6	0.68	-0.63
Long Term Investments	-0.7	-0.55	-0.09	0.33	0.73	-0.08	-0.65	-0.65	-0.6	0.27	-0.75	-0.89	-0.52	-0.25	-0.76	-0.58	0.86		0.61	0.7	-0.6
Net Invested Capital	-0.32	-0.1	-0.55	-0.28	0.89	-0.09	-0.64	-0.86	-0.24	0.19	-0.66	-0.41	-0.04	-0.2	-0.78	-0.85	0.6	0.61		0.94	-0.82
Net Working Capital	-0.4	-0.21	-0.44	-0.19	0.88	-0.16	-0.63	-0.75	-0.3	0.21	-0.69	-0.58	-0.17	-0.19	-0.76	-0.8	0.68	0.7	0.94		-0.79
Capital Stock	0.41	0.22	0.39	0.31	-0.97	0.4	0.52	0.77	0.34	-0.2	0.75	0.36	0.19	0.35	0.88	0.82	-0.63	-0.6	-0.82	-0.79

Click cells to compare fundamentals

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	298.4 M	287.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC